|
A. Service delivery
|
|
|
| 1. Relationship between the delivery system and the recipient and how that affects compliance |
What is the role of the delivery mechanism in achieving compliance? How to train, supervise, motivate, and empower drug distributors? |
Participant observation of MDA, semi-structured interviews, coverage surveys, pilot study |
| 2. Interactions at the point of delivery/distribution |
What conditions are necessary to enhance compliance? What happens at the point of distribution? |
Participant observation, semi-structured interviews |
| 3. Operational considerations to ensure the use of DO-MDA |
What factors must be considered to achieve DO-MDA? Are there best practices to promote? |
Literature review, surveys with health staff and community members, pilot study |
| 4. Best practices for MDA |
What is working in different contexts? How can this information be collated and shared with program managers to enhance their control efforts? |
Identify best practices globally through literature review, discussions with key informants, prepare case studies, disseminate results at scientific meetings |
| 5. Innovative approaches to enhance social mobilization and drug delivery |
Explore use of social media, mobile phone technology, NGO networking, outsourcing, use existing networks (e.g., HIV/AIDS infrastructure, community health workers) |
Case studies to test new methodologies in a way that can be evaluated and replicated |
|
B. Strategic issues for LF and other NTD programs
|
|
|
| 1. Integration of the lessons learned from GPELF into NTD programs |
What are the key lessons from 12 years of GPELF? How might they be applied to NTD programs? |
Literature review, interviews with key informants |
| 2. Sharing of research results and operational knowledge to and in between members of the GPELF community |
How is knowledge shared between programs? How can sharing be enhanced? |
Key informant interviews, exploration of new formats to share information |
| 3. Understanding the changing dynamics of six or more years of MDA in a community/district/country |
What changes might programs expect over time (fatigue, misperceptions, funding, societal changes) and how to address those? |
Document experiences from MDA programs after six or more years and how they adapted to changing conditions |
| 4. Focus on difficult and challenging environments for MDA and identify solutions for improved coverage and compliance |
What are the current difficult environments? What tools can be used to reach these people? How can populations be segmented for mobilization? |
Pilot studies |
| 5. Integration of LF elimination and NTD programs |
How should social mobilization reflect NTD integration? M&E? How does introduction of other NTD programs affect ongoing MDA for LF? |
Literature review, key informant interviews |
|
C. Compliance and the individual
|
|
|
| 1. The impact of systematic non-compliers (SNC) and how to reach them |
Who are SNC? What are their characteristics? What can be done to convince them to comply with MDA? |
Literature review, key informant interviews, pilot studies to test specific interventions |
|
D. Compliance and the community
|
|
|
| 1. Understanding the impact of morbidity management on compliance |
Why does morbidity management influence compliance? How can it be promoted and sustained? Does it have the same effect across contexts? |
Literature review, key informant interviews |
| 2. Engaging the community in an urban environment |
What social groups can be activated for MDA in urban areas? What is the best way to conduct DO-MDA in these environments? |
Pilot studies, literature review |
